EU drugs agency⚠️ #Ketamine is no longer a niche substance in Europe’s drug market. In certain recreational settings, it is becoming more established, raising concerns about its growing use outpacing awareness of the risks.
Find out more in the #EuropeanDrugReport2026: https://www.euda.europa.eu/publications/european-drug-report/2026/other-drugs_en
---
https://nitter.net/EUDrugsAgency/status/2067942794048491808#m
Other drugs – the current situation in Europe (European Drug Report 2026) | The European Union Drugs Agency (EUDA)
Alongside the more well-known substances available on illicit drug markets, a number of other substances with hallucinogenic, anaesthetic, dissociative or depressant properties are used in Europe: these include LSD (lysergic acid diethylamide), hallucinogenic mushrooms, ketamine and GHB (gamma-hydroxybutyrate).